11 сент. 2019

Good result second edition Swim to Fight Cancer Nijmegen

On 8 September 2019, the second edition of Swim to Fight Cancer Nijmegen took place. Eight enthusiastic colleagues participated on behalf of Synthon.

read more
19 авг. 2019

Keystone for new laboratory building Czech Republic

On 11 July, a keystone ceremony took place at our site in Blansko, Czech Republic, to celebrate the start of the construction of a new Analytical…

read more
12 апр. 2019

36 Girls visiting Synthon on Girlsday 2019

36 young visitors spent Girlsday at Synthon doing fun experiments.

read more
27 мар. 2019

Synthon Nijmegen named one of the Top 10 Best Workplaces 2019

Synthon Nijmegen achieved the 9th place on the list of Top 10 Best Multinational Workplaces 2019 in the Netherlands.

read more
08 февр. 2019

Synthon Netherlands again a Great Place to Work

After participating in the survey for the second time, Synthon in the Netherlands was again recognized as a Great Place to Work®.

read more
10 сент. 2018

Great result Synthon at Swim to Fight Cancer

On 9 September, the first edition of Swim to Fight Cancer Nijmegen took place. 21 enthusiastic colleagues, divided into five teams, participated on…

read more
03 сент. 2018

Synthon Chile receives ‘Zero Waste’ certificate

Synthon Chile managed to make a spectacular improvement in its waste recovery; from 30.7% in October 2017 to 100% in April 2018. As a result, our…

read more
05 июл. 2018

‘Young Chemist of the Year’ competition in the Czech Republic

Our affiliate Synthon sro in the Czech Republic has been sponsoring the ‘Young Chemist of the Year’ competition for some time.

read more
28 июн. 2018

Synthon again partner in ‘You dream, we run’ event

Synthon s.r.o. in Blansko has been a general partner of the event for 5 years now and this year the Synthon magenta color was chosen for the shirts of…

read more
31 мая 2018

Synthon to present new and updated Phase I clinical data for [vic-]trastuzumab duocarmazine at 2018 ASCO Annual Meeting

On Saturday 2 June 2018, Synthon will present new and updated data from the Phase I clinical study with [vic-]trastuzumab duocarmazine (also known as…

read more